Dezawa MuseCells® Therapy for Heart Failure, Coronary Artery Disease, and Cardiac Function Improvement
Your cardiologist delivered the verdict three months ago.
Advanced heart failure. Ejection fraction 25%. Your heart barely pumps enough blood to sustain life. You’re exhausted walking to the bathroom. Shortness of breath wakes you at night. Swollen ankles. Constant fatigue. Your quality of life gone.
They optimized your medications—ACE inhibitors, beta blockers, diuretics. You’re maxed out. The next conversation will be about transplant listing or palliative care. You’re 58 years old, and your heart is giving out.
What if there was treatment targeting cardiac tissue repair beyond medication management?
At Muse Cell Procedure, we provide Dezawa MuseCells® therapy for cardiovascular disease—regenerative treatment supporting cardiac tissue repair, promoting new blood vessel formation, and potentially improving heart function when conventional options are exhausted.
For cardiovascular patients seeking to improve cardiac function and quality of life beyond maximum medical therapy, regenerative medicine in Cancun offers cellular-level cardiac support.
Contact Musecell Procedure to discuss cardiovascular treatment options.
Why Cardiovascular Patients Choose Muse Cell Procedure, WPB Florida – USA
- Boosts cardiac performance – enhances the heart’s pumping power
- Encourages angiogenesis – stimulates new blood‑vessel growth
- Lowers cardiac fibrosis – reduces scar tissue buildup
- Improves exercise tolerance – increases stamina and endurance
- Elevates quality of life – fewer symptoms, better daily function
- Tames inflammation – targets chronic cardiac tissue irritation
- Supports remodeling – may halt further deterioration
- Partnered with MuseCell Innovations® – pharmaceutical‑grade stem cells
- COFEPRIS‑certified (or equivalent U.S. certification) – a medical‑grade facility
Understanding Cardiovascular Disease
The Ultimate Mortality Driver
Per the American Heart Association, cardiovascular disease remains the world’s leading killer—surpassing all cancers combined.
Typical conditions:
- Heart failure (reduced ejection fraction)
- Coronary artery disease
- Post‑myocardial infarction scarring
- Cardiomyopathy (weakened muscle)
- Peripheral artery disease
- Ischemic heart disease
Millions endure limited cardiac function because standard therapies fall short.
How the Heart Gets Weaker
| Mechanism | What Happens |
|---|---|
| Ischemia | Reduced blood flow starves heart cells, leading to death and scar formation. |
| Infarction | A heart attack kills muscle; dead tissue becomes fibrotic scar while remaining tissue over‑works and eventually fails. |
| Fibrosis | Scar tissue replaces functional myocardium, cutting contractility (see Circulation Research). |
| Remodeling | The heart enlarges and reshapes itself to compensate—an adaptation that ultimately worsens performance. |
| Chronic inflammation | Persistent inflammatory signals accelerate damage and blunt repair efforts. |
These intertwined processes drive progressive cardiac dysfunction.
💡 Quick Fact: Adult heart muscle has a minimal natural regenerative capacity, so once tissue is lost, conventional medicine can’t rebuild it—underscoring the value of cell‑based approaches like Muse Cell therapy.
